Kirsty® (formerly Kixelle®)
ACTIVE PRINCIPLE:
insulin aspart
INDICATION:
Diabetes Mellitus
DATE:
05/02/2021
STATUS:
Authorized
Biosimilar medicine authorized by the European Commission
ACTIVE PRINCIPLE:
insulin aspart
INDICATION:
Diabetes Mellitus
DATE:
05/02/2021
STATUS:
Authorized
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.